Are you suffering from excessive sleepiness, sleep paralysis, and hallucinations? If that’s because you have a sleep disorder called Narcolepsy, you could be a part of a new medication research study being conducted worldwide.

Okanagan Clinical Trials in Kelowna is looking for anyone with Narcolepsy to participate in a study for an investigational medication that treats excessive daytime sleepiness in type one and type two Narcolepsy.

“Narcolepsy often takes years to recognize and is often misdiagnosed,” says Dr. Paul Latimer, psychiatrist and principal investigator for Okanagan Clinical Trials. “It is estimated that only 25% people who have Narcolepsy have been diagnosed and are receiving treatment. Narcolepsy affects an estimated 3 million people worldwide.”

A total of 264 patients will participate in the study worldwide. Eligible volunteers for this study will be men and women above the age of 16 who have documented evidence of a diagnosis of narcolepsy.

For more information, visit Okanagan Clinical Trials online or by phone at 250-862-8141.